$PULM Cashflow Statement | Understand Stock

$PULM

$1.44 -$0.04 (2.7%) Close

$PULM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of operating lease right-of-use asset
Stock-based compensation
Impairment of goodwill
Loss on disposals
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Other long-term assets
Accounts payable
Accrued expenses and other current liabilities
Operating lease liability
Deferred revenue

Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Net cash used in investing activities
Proceeds from the issuance of preferred stock and common stock warrants, net of issuance costs
Proceeds from issuance of common stock, net of issuance costs
Proceeds from exercise of common stock warrants
Preferred stock issuance costs
Net cash provided by financing activities
Net decrease in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash — beginning of period
Cash, cash equivalents and restricted cash — end of period
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Cash and cash equivalents
Restricted cash
Long-term restricted cash

Supplemental disclosures of non-cash investing and financing information:
Reduction of operating lease right-of-use asset and lease liability upon lease modification
Operating lease right-of-use asset obtained in exchange for operating lease liability
Preferred stock issuance costs associated with placement agent warrants
Beneficial conversion feature of preferred stock
Deemed dividend related to beneficial conversion feature of preferred stock
Purchases of property and equipment not yet paid
Conversion of preferred stock to common stock
Fixed asset purchases in accounts payable
Issuance costs in accounts payable

Comments